Jose L Gorriz
Overview
Explore the profile of Jose L Gorriz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
623
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kotwal S, Perkovic V, Jardine M, Kim D, Shah N, Lin E, et al.
JAMA Netw Open
. 2024 Dec;
7(12):e2449998.
PMID: 39661388
Importance: Chronic kidney disease (CKD) is a global health priority affecting almost 1 billion people. New therapeutic options and clinical trial innovations such as adaptive platform trials provide an opportunity...
2.
Gorgojo-Martinez J, Gorriz J, Cebrian-Cuenca A, Castro Conde A, Velasco Arribas M
J Clin Med
. 2024 Nov;
13(21).
PMID: 39518647
SGLT-2 inhibitors (SGLT-2is) are considered to be a first-line treatment for common conditions like type 2 diabetes, chronic kidney disease, and heart failure due to their proven ability to reduce...
3.
Apperloo E, Gorriz J, Soler M, Cigarran Guldris S, Cruzado J, Puchades M, et al.
Nat Med
. 2024 Oct;
31(1):278-285.
PMID: 39455729
Semaglutide reduces albuminuria and the risk of kidney disease progression in patients with type 2 diabetes and chronic kidney disease (CKD). We conducted a randomized placebo-controlled double-blind clinical trial in...
4.
Diaz J, Lidon L, Sauri I, Fernandez A, Grau M, Gorriz J, et al.
Nephrol Dial Transplant
. 2024 Jul;
40(2):385-392.
PMID: 39049453
Background And Hypothesis: The aim was to assess incidence of acute kidney disease and disorders (AKD) and acute kidney injury (AKI) episodes and their impact on progression of renal dysfunction...
5.
Molina P, Molina M, Carrero J, Escudero V, Torralba J, Castro-Alonso C, et al.
J Clin Med
. 2023 Dec;
12(24).
PMID: 38137700
Data suggest that non-calcium-based binders, and specifically sevelamer, may lead to lower rates of death when compared with calcium-based binders in end-stage renal disease (ESRD) patients. However, the association between...
6.
Lieverse T, Puchades M, Mulder U, Provenzano M, Krenning G, Jongs N, et al.
Diabetes Obes Metab
. 2023 Nov;
26(2):576-582.
PMID: 37926904
Aim: Sodium-glucose co-transporter 2 inhibitors and mineralocorticoid receptor antagonists reduce albuminuria and the risk of kidney failure. The aim of this study was to investigate the effects of both agents...
7.
Bover J, Masso E, Gifre L, Alfieri C, Soler-Majoral J, Fusaro M, et al.
Nutrients
. 2023 Apr;
15(7).
PMID: 37049415
Chronic kidney disease (CKD) is a highly prevalent condition worldwide in which the kidneys lose many abilities, such as the regulation of vitamin D (VD) metabolism. Moreover, people with CKD...
8.
Bover J, Trinidad P, Jara A, Soler-Majoral J, Martin-Malo A, Torres A, et al.
Nefrologia (Engl Ed)
. 2023 Mar;
42(6):645-655.
PMID: 36925324
Although phosphorus is an essential element for life, it is not found in nature in its native state but rather combined in the form of inorganic phosphates (PO), with tightly...
9.
Gorriz J, Romera I, Cobo A, OBrien P, Merino-Torres J
Diabetes Ther
. 2022 Feb;
13(3):389-421.
PMID: 35175551
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are incretin-mimetic agents that are effective adjuncts in the treatment of diabetes. This class of medications is also associated with promoting weight loss and...
10.
Neuen B, Oshima M, Perkovic V, Agarwal R, Arnott C, Bakris G, et al.
Eur Heart J
. 2021 Aug;
42(48):4891-4901.
PMID: 34423370
Aims: Hyperkalaemia is a common complication of type 2 diabetes mellitus (T2DM) and limits the optimal use of agents that block the renin-angiotensin-aldosterone system, particularly in patients with chronic kidney...